News | Ultrasound Imaging | October 15, 2021

Performance, intelligence and versatility, the V8 is optimized for use in busy ultrasound departments in the USA and around the world 

NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, introduces the V8; a high-end ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals.

Designed for a wide range of diagnostic medical ultrasound departments, the V8 Ultrasound system combines performance and intelligence to elevate diagnostic confidence. (Photo: Business Wire)


October 15, 2021 — NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, introduces the V8; a high-end ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. The V8 was recently cleared by the U.S. Food and Drug Administration for commercial use in the USA. The feature-packed device includes two new artificial intelligence (AI) functions. The first is "NerveTrack", an exciting AI technology that detects the location of nerves during live scanning. The second is “UterineAssist”, which detects tissue changes and assists the user with measurements of the uterus.

“We are pleased to launch the V8. We designed it with the user in mind, from its premium imaging engine to its ergonomic design," said David Legg, Vice President, Ultrasound and Digital Radiography, NeuroLogica. “The “V” in “V8” stands for “versatile” because a wide range of departments from obstetrics to radiology and orthopedics to cardiology can make use of its complex functions. We anticipate the V8 to become a flagship product within the high-end ultrasound category.”

Crystal Architecture is the core of the V8’s exceptional image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

Samsung is continuously seeking out new ways to help professionals obtain reliable answers with greater image clarity, enhanced accuracy and improved work efficiency. The V8 is equipped with many premium technologies such as:

  • ShadowHDR, designed to suppress shadows and enhance the clarity of displayed grayscale images.
  • S-Shearwave Imaging, which provides information about tissue stiffness as a result of disease using ultrasonic transverse elasticity.
  • S-Fusion technology, which allows synchronous alignment of medical images of ultrasound with one or more cross-sectional studies such as MRI, which are instantly reconstructed in the corresponding plane.
  • MV-Flow, which enhances the visualization of low-flow blood flow states.

The V8 also has various 3D, 4D and 5D technologies that allow the user to view anatomy with exceptional detail. One tool, 5D CNS+, simplifies fetal brain assessment by automatically providing nine planes simultaneously with biometric measurements. The V8 will deliver a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

For more information: www.neurologica.com/


Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 05, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Computed Tomography (CT)

Feb. 4, 2026 — A new review published in the American Journal of Roentgenology (AJR) finds that advances in CT ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 27, 2026 — Siemens Healthineers and World Athletics have joined forces to inform medical teams how point-of-care ...

Time January 27, 2026
arrow
Subscribe Now